Treatment of Circadian Rhythm Sleep-Wake Disorders.
Level 5 - mechanism / opinion, no new human data
Narrative review without systematic search or meta-analytic data
PubMed 34493186 · doi:10.2174/1570159X19666210907122933
What was done
The authors conducted a narrative review of circadian rhythm sleep-wake disorders (CRSWDs), focusing on intrinsic CRSWD epidemiology, etiology, diagnostic evaluation, diagnostic criteria, and management approaches. They categorized CRSWDs into intrinsic and extrinsic types and described routine diagnostic tools (sleep diaries, actigraphy, dim light melatonin onset, core body temperature minimum) and therapeutic interventions (sleep health education, chronotherapy, light therapy, melatonin, and hypnotic pharmacotherapy).
What was found
The abstract presents a qualitative overview of the classification, diagnosis, and treatment pathways for CRSWDs. No quantitative data, numbers of reviewed studies, effect sizes, or statistical findings are reported.
Why it matters
CRSWDs are frequently misidentified as primary insomnia or non-specific sleep disruptions, leading to ineffective care. Synthesizing diagnostic markers and targeted circadian therapies helps guide appropriate clinical differentiation and management.
Limits
As a narrative review, it lacks a systematic literature search, formal risk-of-bias assessment, or meta-analytic pooling. The abstract provides no quantitative outcome comparisons, specific sample sizes, or data on relative treatment efficacy.
Cited by
- supports Melatonin levels are naturally low during the daytime and high at night, causing circadian misalignment for individuals attempting to sleep during the day.